The Scientific World Journal

The Scientific World Journal / 2006 / Article

Research Article | Open Access

Volume 6 |Article ID 597846 | https://doi.org/10.1100/tsw.2006.347

Sergey V. Malkov, Vladimir V. Markelov, Gleb Y. Polozov, Boris I. Barabanschikov, Alexander Y. Kozhevnikov, Maxim V. Trushin, "Significant Delay of Lethal Outcome in Cancer Patients Due to Peroral Administration of Bacillus oligonitrophilus KU-1", The Scientific World Journal, vol. 6, Article ID 597846, 11 pages, 2006. https://doi.org/10.1100/tsw.2006.347

Significant Delay of Lethal Outcome in Cancer Patients Due to Peroral Administration of Bacillus oligonitrophilus KU-1

Academic Editor: Joav Merrick
Received16 Apr 2006
Revised13 Jun 2006
Accepted13 Jun 2006

Abstract

Treatment of cancer patients remains a serious medical problem and the development of alternative treatment strategies is therefore of great importance. In this connection, we developed a new bacterial-based, anticancer method. Ten cancer patients (three males, seven females) were involved in this study. Bacterial suspension of stationary phase Bacillus oligonitrophilus KU-1 was used as a remedy for peroral administration. In five patients, side effects (sicchasia, slight blood, and intracranial pressure gain) were detected, but all patients showed significant delay of lethal outcome without serious side effects. In conclusion, the suggested method was, in our opinion, a good alternative to conventional chemo- and radiotherapy techniques. In order to evaluate its efficiency for various tumors, a double-blind, placebo-controlled, multicenter study is needed.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views60
Downloads481
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.